These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11363530)

  • 1. Scanning the headlines with Jay A. Levy, MD. Interview by Mark Mascolini.
    Levy JA
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):40-4. PubMed ID: 11363530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Kaposi's sarcoma].
    Boué F; Lebbé C
    Bull Cancer; 2003 May; 90(5):393-8. PubMed ID: 12850761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
    Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
    Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and the cells it infects: sorting the latent from the labile. An interview with Mike McCune, MD, PhD. Interview by Mark Mascolini.
    McCune JM
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):20-2, 25-7, 41. PubMed ID: 11363326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
    Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
    AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.
    Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S
    AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How far can you knock down HIV? An interview with David D. Ho, MD. Interview by Mark Mascolini.
    Ho DD
    J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):40-4. PubMed ID: 11364429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
    Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
    J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puzzling out new data on Kaposi's sarcoma.
    AIDS Alert; 1998 Jun; 13(6):suppl 1-3. PubMed ID: 11365464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical progress and transmission perils stressed at second human retroviruses conference.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Mar; 1(2):19-29. PubMed ID: 11362310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N; Spira T; Lam L; Corchero JL; Luo W
    J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wide-ranging progress on KS therapies.
    Horn T; Gilden D
    GMHC Treat Issues; 1998 Feb; 12(2):8-16. PubMed ID: 11365219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
    Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
    Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What's new in Kaposi's sarcoma research.
    Trethewey P
    STEP Perspect; 1997; 9(3):9-10. PubMed ID: 11364938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD8 cell antiviral factor: an interview with immunologist Jay Levy, MD. Interview by Mark Mascolini.
    Levy J
    BETA; 1995 Jun; ():18-24. PubMed ID: 11362540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
    Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
    Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated Kaposi sarcoma: pathogenic mechanisms.
    Feller L; Wood NH; Lemmer J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):521-9. PubMed ID: 17142074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
    Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
    Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.